Deal Announcements

aTyr Pharma Nets $12 Million Series C Venture Capital

Thursday, July 30, 2009 5:58:00 AM PDT | VentureDeal Staff

San Diego, California  --  Pharmaceutical company aTyr Pharma has raised $12 million in its third round of institutional venture capital funding.

aTyr says that it is "developing a novel class of naturally occurring protein Biologics for human therapeutics."

Investors in the company include Alta Partners, Cardinal Partners and Polaris Venture Partners. The company said the funding proceeds would be used to continue development of its lead drug candidate and expand its discovery and preclinical platforms.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1